Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 220

1.

Prospects and limitations of post-transplantation alloantibody detection in renal transplantation.

Böhmig GA, Bartel G, Regele H, Wahrmann M.

Hum Immunol. 2009 Aug;70(8):640-4. doi: 10.1016/j.humimm.2009.04.014. Epub 2009 Apr 15.

PMID:
19375475
2.

Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.

Vlad G, Ho EK, Vasilescu ER, Colovai AI, Stokes MB, Markowitz GS, D'Agati VD, Cohen DJ, Ratner LE, Suciu-Foca N.

Hum Immunol. 2009 Aug;70(8):589-94. doi: 10.1016/j.humimm.2009.04.018. Epub 2009 Apr 15.

PMID:
19375470
3.

Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay.

Phelan D, Mohanakumar T, Ramachandran S, Jendrisak MD.

Hum Immunol. 2009 Aug;70(8):584-8. doi: 10.1016/j.humimm.2009.05.007. Epub 2009 May 27.

PMID:
19477211
4.

Emerging role of donor-specific anti-human leukocyte antigen antibody determination for clinical management after solid organ transplantation.

Zeevi A, Lunz JG 3rd, Shapiro R, Randhawa P, Mazariegos G, Webber S, Girnita A.

Hum Immunol. 2009 Aug;70(8):645-50. doi: 10.1016/j.humimm.2009.06.009. Epub 2009 Jun 12.

PMID:
19527760
5.

Clinical significance of anti-HLA antibodies detected by Luminex: enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools.

Eng HS, Bennett G, Bardy P, Coghlan P, Russ GR, Coates PT.

Hum Immunol. 2009 Aug;70(8):595-9. doi: 10.1016/j.humimm.2009.06.010. Epub 2009 Jun 12.

PMID:
19527759
6.

Antibody-mediated rejection: treatment alternatives and outcomes.

Singh N, Pirsch J, Samaniego M.

Transplant Rev (Orlando). 2009 Jan;23(1):34-46. doi: 10.1016/j.trre.2008.08.004. Review.

PMID:
19027615
7.

Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.

Aubert V, Venetz JP, Pantaleo G, Pascual M.

Hum Immunol. 2009 Aug;70(8):580-3. doi: 10.1016/j.humimm.2009.04.011. Epub 2009 Apr 16.

PMID:
19375474
8.

Clinical relevance of pretransplant human leukocyte antigen donor-specific antibodies in renal patients waiting for a transplant: a risk factor.

Gupta A, Sinnott P.

Hum Immunol. 2009 Aug;70(8):618-22. doi: 10.1016/j.humimm.2009.04.020. Epub 2009 Apr 15.

PMID:
19374932
9.

Alloantibodies and outcomes of deceased donor kidney allografts.

Cinti P, Pretagostini R, Lai Q, Tamburro ML, Rossi M, Poli L, Berloco P.

Hum Immunol. 2009 Aug;70(8):651-4. doi: 10.1016/j.humimm.2009.06.008. Epub 2009 Jun 12.

PMID:
19527761
10.

Mechanisms of alloantibody production in sensitized renal allograft recipients.

Stegall MD, Dean PG, Gloor J.

Am J Transplant. 2009 May;9(5):998-1005. doi: 10.1111/j.1600-6143.2009.02612.x. Review.

11.

Human leukocyte antigen antibody detection and kidney allocation within Eurotransplant.

Claas FH, Doxiadis II.

Hum Immunol. 2009 Aug;70(8):636-9. doi: 10.1016/j.humimm.2009.04.010. Epub 2009 Apr 16.

PMID:
19375467
12.

Clinical relevance of HLA antibody monitoring after kidney transplantation.

Morath C, Opelz G, Zeier M, Süsal C.

J Immunol Res. 2014;2014:845040. doi: 10.1155/2014/845040. Epub 2014 Oct 13. Review.

13.

Post-transplantation antibody monitoring and HLA antibody epitope identification.

Cai J, Terasaki PI.

Curr Opin Immunol. 2008 Oct;20(5):602-6. doi: 10.1016/j.coi.2008.07.008. Epub 2008 Aug 11. Review.

PMID:
18692134
14.

Clinical relevance of human leukocyte antigen antibodies in kidney transplantation from deceased donors: the North Italy Transplant program approach.

Poli F, Cardillo M, Scalamogna M.

Hum Immunol. 2009 Aug;70(8):631-5. doi: 10.1016/j.humimm.2009.06.006. Epub 2009 Jun 12.

PMID:
19527758
15.

Antibody-mediated rejection.

Akalin E, Watschinger B.

Semin Nephrol. 2007 Jul;27(4):393-407. Review.

PMID:
17616272
16.

Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients.

Stastny P, Ring S, Lu C, Arenas J, Han M, Lavingia B.

Hum Immunol. 2009 Aug;70(8):600-4. doi: 10.1016/j.humimm.2009.04.017. Epub 2009 Apr 15.

PMID:
19375468
17.

Back to the future: application of contemporary technology to long-standing questions about the clinical relevance of human leukocyte antigen-specific alloantibodies in renal transplantation.

Taylor CJ, Kosmoliaptsis V, Summers DM, Bradley JA.

Hum Immunol. 2009 Aug;70(8):563-8. doi: 10.1016/j.humimm.2009.05.001. Epub 2009 May 13.

PMID:
19445992
18.

Donor-reactive HLA antibodies in renal allograft recipients: considerations, complications, and conundrums.

Gebel HM, Moussa O, Eckels DD, Bray RA.

Hum Immunol. 2009 Aug;70(8):610-7. doi: 10.1016/j.humimm.2009.04.012. Epub 2009 Apr 16.

PMID:
19375473
19.

The development of chronic renal allograft rejection may be predicted early following transplantation.

O'Malley KJ, Cook DJ, Flechner SM, McCarthy JF, Thorne NA, Boparai N, Mastroianni BA, Papajcik DA, Modlin CS, Goldfarb DA, Novick AG.

Transplant Proc. 1999 Feb-Mar;31(1-2):1352-3. No abstract available.

PMID:
10083599
20.

Detailed examination of HLA antibody development on renal allograft failure and function.

Zhu L, Lee PC, Everly MJ, Terasaki PI.

Clin Transpl. 2008:171-87.

PMID:
19711514

Supplemental Content

Support Center